Harvest Health & Recreation Inc. Announces Acquisition of Arizona Natural Selections

▴ Harvest Health & Recreation Inc. Announces Acquisition of Arizona Natural Selections
Harvest Health & Recreation Inc. a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., recently announced the acquisition of Arizona Natural Selections.

Harvest Health & Recreation Inc. a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., recently announced the acquisition of Arizona Natural Selections, including the company's four vertical medical licenses in Arizona for a non-material undisclosed amount of stock. With this acquisition Harvest owns and operates 14 medical dispensaries, four cultivation facilities, and three processing facilities in its home state of Arizona, a total of 15 vertical licenses. On a pro forma basis, including pending acquisitions, Harvest has a total of 22 vertical licenses in Arizona.

The four licenses acquired through the agreement include retail locations: Green Desert Patient Center of Peoria, Inc., Green Sky Patient Center of Scottsdale North, Inc., The Giving Tree Wellness Center of Mesa, Inc. and a fourth location to be opened, each of which currently conducts business under the retail brand name Arizona Natural Selections.

The acquisition will provide Harvest with two operational cultivation facilities: a 55,000 sq. ft. indoor cultivation and production facility in Phoenix and a 322-acre site of which 25 acres are zoned for cannabis with 70,000 square feet of greenhouse in Willcox. The acquisition includes the Darwin line of precision-dosed cannabis products.

"We are excited to further deepen our operations in our home state of Arizona expanding our cultivation, processing, and retail operations," said Harvest CEO Steve White. "We will look to further the existing reputation and operational excellence Arizona Natural Selections has established across the state and are eager to welcome new members into the Harvest family."

"We're extremely pleased to have found a partner like Harvest, whose values align with ours and whose capabilities will enhance our ability to deliver high-quality products to our patients," said Kurt Merschman, CEO of Arizona Natural Selections. "With Harvest's exceptional reputation, commitment to Arizona and experienced operations team, we have no doubt we'll be able to provide an even greater level of care and service to our patients."

Tags : #Harvesthealthrecreation #Arizonanaturalselection #Cannabis

About the Author


Team Medicircle

Related Stories

18 Jun

FDA approves nasal antihistamine for nonprescription use

Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies.

View
23 Dec

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain

View
18 Dec

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.

View
07 Oct

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera

View
18 Aug

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization

View
30 Jul

Food Allergies: All that you have to know

Skin prick testing can in some cases produce bogus negative or bogus positive outcomes.

View
21 May

Cipla receives final approval for Migranal

Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation

View
12 May

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US

View
28 Feb

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025